Clinical Trials Directory

Trials / Completed

CompletedNCT01791712

Efficacy of Online Hemodiafiltrationlysis in Cytokine Removal

Enhanced Vascular Endothelial Growth Factor and Pro-inflammatory Cytokine Clearances With On-line Hemodiafiltration Versus High-flux Hemodialysis in Sepsis-related Acute Kidney Injury Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Following the concept of "peak concentration hypothesis", which suggest the cutting peak of pro- and anti-inflammatory mediators would result in restoring a situation of immunohomeostasis. The investigators conducted the prospective randomized controlled trial aimed to compare the clearance efficacy between on-line hemodiafiltration and high-flux hemodialysis in sepsis-related acute kidney injury patients. The lowering cytokines level during sepsis is postulated to improved outcomes in sepsis.

Detailed description

1. Blood samples were taken from patients before and at the end of 4-hour in the first dialysis session. The percentage of reductions were calculated from the before and ending samples. The values of postfilter samples were corrected for changes in plasma volume, based on hemoglobin (Hb) of prefilter. 2. VEGF and other cytokines (IL-6, IL-8, IL-10, and TNF-α) were determined in the plasma separated from EDTA blood. After collection, plasma separation was achieved by centrifugation for 10 min at 1,500 g. Immediately after separation, the samples were stored at -70 ºC until further analysis. 3. All determinations were carried out in duplicate. The panels of cytokines (VEGF, IL-6, IL-8, IL-10, and TNF-α) were measured using the Luminex xMap-based multiplex technology. Assays were performed using the MILLIPLEX MAP (multi-analyte panels) 5-plex Cytokine Kit (Millipore, Billerica, MA) on the Luminex® instrument according to the manufacturer's procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREOn-line hemodiafiltrationpre-dilution 40% of blood flow rate blood flow rate 300-350 ml/min dialysate flow rate 800 ml/min
PROCEDUREHigh-flux Hemodialysisblood flow rate 300-350 ml/min dialysate flow rate 800 ml/min

Timeline

Start date
2010-01-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2013-02-15
Last updated
2013-02-15

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01791712. Inclusion in this directory is not an endorsement.